A novel blood-based mRNA genomics technology for cancer diagnosis and treatment

Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment

Biography:

Rajvir Dahiya holds Ph.D. in Experimental Medicine from Post Graduate Institute of Medical Education and Research Chandigarh, India, post-doctoral fellowship in medical oncology research from the University of Chicago Pritzker School of Medicine, M.D. from the Kagoshima University Faculty of Medicine, Kagoshima, Japan and D.Sc. from the Osaka University Graduate School of Medicine, Osaka, Japan. He became director of Oncology Urology Oncology Research Center at the UCSF/VAMC in 1991. After 34 years of service, he retired as a Professor Emeritus and Director of Urology Research Center. Dahiya has published more than 550 original research manuscripts. Dahiya’s world ranking in medicine is 4759 and USA ranking is 2644 with more than 35,500 research citations and D-index of 107 in 2024. He has written books and holds multiple patents in oncology. Based on the NIH and VA data base NIH Reporter and Grantome, Dahiya's research programs were supported (99 times awarded) by the NIH and VA. Currently, he is an associate editor of “Clinical Cancer Research” journal.